+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Varicose Vein Treatments Market 2021-2026

  • ID: 5319360
  • Report
  • April 2021
  • Region: Global
  • 65 Pages
  • BCC Research
UP TO OFF until May 31st 2022

FEATURED COMPANIES

  • Angiodynamics Inc.
  • Biolitec A
  • Boston Scientific Corp.
  • Candela Medical
  • Energist Medical Group
  • Eufoton Srl

Varicose veins treatment includes procedure types such as sclerotherapy, endovenous ablation and surgical procedures. This report is an analytical business tool that offers a thorough evaluation of the global market.




This study provides an overview of varicose veins treatments devices and their uses in the treatment of venous diseases such as varicose veins and venous insufficiency diseases. In addition, it gives a detailed analysis of the competitive environment. It covers a wide variety of devices and techniques that greatly improve the treatment of varicose veins. This study includes information about emerging treatment procedures, devices, market players, and other pertinent information related to the healthcare, pharmaceutical, and medical device industry.


The format of this study includes:


  • Detailed descriptions of the disease including classification, anatomy, pathophysiology and risk factors.
  • Detailed descriptions and analyses of treatments and procedures
  • Market characterization, market size, and segmentation (by region and treatment).
  • Market drivers and restraints.
  • Detailed market projections through 2026.
  • Key marketed products along with information about their regulatory status.
  • Analysis of regulatory structure.
  • Discussions about the future of varicose vein treatments.
  • Profiles of market participants.

The Report Includes:


  • An overview of the global varicose veins treatment market
  • Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation of the current market size and market forecast for varicose veins treatment, and corresponding market share analysis by product type, end user and geographic region
  • Evaluation of the impact of demographic, economic, and other factors that will drive future demand for the market
  • Impact of COVID-19 on the medical devices market as well as the market for vascular surgery and venous procedures
  • Highlights of current and future market potential of generic drugs along with a detailed review of technology updates, regulatory scenario and product pipeline analysis within the marketplace
  • Company profiles of the market leading participants
Frequently Asked Questions about the Global Varicose Vein Treatments Market

What is the estimated value of the Global Varicose Vein Treatments Market?

The Global Varicose Vein Treatments Market was estimated to be valued at $1040.3 Million in 2021.

What is the growth rate of the Global Varicose Vein Treatments Market?

The growth rate of the Global Varicose Vein Treatments Market is 6.7%, with an estimated value of $1435.7 Million by 2026.

What is the forecasted size of the Global Varicose Vein Treatments Market?

The Global Varicose Vein Treatments Market is estimated to be worth $1435.7 Million by 2026.

Who are the key companies in the Global Varicose Vein Treatments Market?

Key companies in the Global Varicose Vein Treatments Market include Angiodynamics Inc., Biolitec A, Boston Scientific Corp., Candela Medical, Energist Medical Group, Eufoton Srl, Medtronic and Teleflex Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Angiodynamics Inc.
  • Biolitec A
  • Boston Scientific Corp.
  • Candela Medical
  • Energist Medical Group
  • Eufoton Srl

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related Reports


Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
  • Overview of Disease
  • Risk Factors, Anatomy, and Pathophysiology
  • Risk Factors
  • Anatomy
  • Pathophysiology
  • Clinical Presentation
  • Diagnosis
  • Clinical Examination
  • Role of Imaging
  • Prognosis
  • Management of Varicose Veins
  • Lifestyle Modification
  • Compression Therapy
  • Sclerotherapy
  • Endovenous Ablation Therapy
  • Surgical Options


Chapter 4 Market Dynamics
  • Market Drivers
  • Prevalence of Obesity
  • Prevalence of Deep Vein Thrombosis
  • Incidence of Chronic Venous Diseases
  • Minimally Invasive Surgical Procedures
  • Growing Markets: Emerging Economies
  • Restraints and Challenges
  • Changing Decision Makers
  • Influence of New Entities
  • Price Pressure
  • Regulatory Environment
  • Compliance Rules
  • End Users: Lack of Training


Chapter 5 Impact of COVID-19 on the Global Market
  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Incubation Period
  • Impact of COVID-19 on the Medical Device Market
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism
  • Impact of COVID-19 on Vascular Surgery and Venous Procedures
  • The Status Quo Disrupted


Chapter 6 Regulatory Scenario
  • Regulations and Legislation
  • Europe
  • U.S.
  • Japan


Chapter 7 Market Size and Analysis
  • Market Breakdown by Product Type
  • Overview
  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation and Stripping
  • Market Breakdown by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World


Chapter 8 Company Profiles
  • Angiodynamics Inc.
  • Biolitec A
  • Boston Scientific Corp.
  • Candela Medical
  • Energist Medical Group
  • Eufoton Srl
  • Medtronic
  • Quanta System S.P.A.
  • Teleflex Inc.


List of Tables
Summary Table: Global Market for Varicose Vein Treatments, by Type, Through 2026
Table 1: Risk Factors for Varicose Veins
Table 2: CEAP Classification System and Reporting Standards for Vascular Diseases
Table 3: Incidence of Complications after Different Modalities of Varicose Vein Treatments
Table 4: BMI Categories Based on Increasing Health Risks
Table 5: Trends in Obesity in the World’s Population, by Segment, Through 2021
Table 6: U.S. Obesity and Severe Obesity vs. the General Adult Population, by Segment, Through 2021
Table 7: Distribution of Clinical Symptoms of COVID-19
Table 8: Class I and II Exempt Devices
Table 9: CPT Codes for Endovenous Ablation
Table 10: CPT Codes for Ambulatory Phlebectomy
Table 11: CPT Codes for Ligation and Stripping
Table 12: CPT Codes for Endoscopic Ligation and Stripping of Perforating Vein
Table 13: CPT Codes for Sclerotherapy
Table 14: Global Market for Varicose Vein Treatments, by Type, Through 2026
Table 15: Approved Endovenous Ablation Devices
Table 16: Global Market for Varicose Vein Treatments, by Region, Through 2026
Table 17: North American Market for Varicose Vein Treatments, by Type, Through 2026
Table 18: North American Market for Varicose Vein Treatments, by Country, Through 2026
Table 19: North American Market for Varicose Vein Treatments, by End User, Through 2026
Table 20: European Market for Varicose Vein Treatments, by Type, Through 2026
Table 21: European Market for Varicose Vein Treatments, by Country, Through 2026
Table 22: European Market for Varicose Vein Treatments, by End User, Through 2026
Table 23: Asia-Pacific Market for Varicose Vein Treatments, by Type, Through 2026
Table 24: Asia-Pacific Market for Varicose Vein Treatments, by Country, Through 2026
Table 25: Asia-Pacific Market for Varicose Vein Treatments, by End User, Through 2026
Table 26: RoW Market for Varicose Vein Treatments, by Type, Through 2026
Table 27: RoW Market for Varicose Vein Treatments, by End User, Through 2026
Table 28: AngioDynamics: Financials, 2018-2020
Table 29: Boston Scientific Corp.: Product Portfolio
Table 30: Boston Scientific Corp.: Recent Developments, 2015-2020
Table 31: Medtronic: Product Portfolio
Table 32: Medtronic: Varicose Vein Treatment Devices
Table 33: Medtronic: Revenue, 2018-2020


List of Figures
Summary Figure: Global Market Shares of Varicose Vein Treatments, by Type, 2020
Figure 1: Trends in Obesity in the World's Population, by Segment, 2012-2021
Figure 2: U.S. Obesity and Severe Obesity vs. General Population, by Segment, 2016 and 2021
Figure 3: Medical Device Marketing Process in the U.S.
Figure 4: Global Market Shares of Varicose Vein Treatments, by Type, 2020
Figure 5: Global Market for Endovenous Ablation Devices, 2020-2026
Figure 6: Global Market Shares of Endovenous Ablation Devices, by Type, 2020
Figure 7: Global Market for Sclerotherapy Treatments, 2020-2026
Figure 8: Global Market Shares of Sclerotherapy Treatments, by Type, 2020
Figure 9: Global Market for Surgical Ligation and Stripping, 2020-2026
Figure 10: Global Market Shares of Varicose Vein Treatments, by Region, 2020
Figure 11: AngioDynamics: Revenue Share, by Segment, 2020
Figure 12: AngioDynamics: Revenue Share, by Region/Country, 2020
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Angiodynamics Inc.
  • Biolitec A
  • Boston Scientific Corp.
  • Candela Medical
  • Energist Medical Group
  • Eufoton Srl
  • Medtronic
  • Quanta System S.P.A.
  • Teleflex Inc.
Note: Product cover images may vary from those shown